PCG
BEAT

Private Capital Group’s BioTelemetry, Inc. BEAT Stock Holding History

Private Capital Group’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-51
Closed -$4K – 2226
2020
Q4 		$4K Sell
51
-174
-77% -$9.11K ﹤0.01% 1638
2020
Q3 		$10K Sell
225
-1,037
-82% -$43.3K ﹤0.01% 1334
2020
Q2 		$57K Buy
1,262
+116
+10% +$5.2K 0.01% 656
2020
Q1 		$44K Hold
1,146
– – 0.01% 707
2019
Q4 		$53K Hold
1,146
– – 0.01% 715
2019
Q3 		$47K Sell
1,146
-241
-17% -$10.4K 0.01% 806
2019
Q2 		$62K Buy
1,387
+239
+21% +$12.6K 0.01% 572
2019
Q1 		$72K Sell
1,148
-66
-5% -$4.53K 0.01% 609
2018
Q4 		$73K Sell
1,214
-100
-8% -$6K 0.02% 496
2018
Q3 		$84K Sell
1,314
-73
-5% -$4.07K 0.02% 492
2018
Q2 		$62K Buy
1,387
+48
+4% +$1.91K 0.01% 608
2018
Q1 		$42K Buy
1,339
+168
+14% +$5.53K 0.01% 767
2017
Q4 		$35 Buy
+1,171
New +$33.9K 0.01% 837

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Private Capital Group's BEAT Position: Q1 2021 in Review

Private Capital Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 51 shares — an estimated $4K sold.

Private Capital Group first reported a position in BEAT in Q4 2017 and held it in 13 quarters. The position peaked at $84K in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Private Capital Group reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Private Capital Group sold 51 BioTelemetry, Inc. shares in Q1 2021, an estimated $4K.
  • Private Capital Group first reported a position in BioTelemetry, Inc. in Q4 2017 and held it in 13 quarters.
  • Private Capital Group's BioTelemetry, Inc. position peaked at $84K in Q3 2018.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Private Capital Group's 13F filing for Q1 2021, filed 12 Apr 2021.